Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The increase in aging patients with more complicated medical histories and procedures makes it important to evaluate chemoprevention of venous thromboembolism (VTE). Bahl and colleagues spearheaded a retrospective cohort study of 3498 patients admitted for otolaryngologic surgery between September 1, 2003, and June 30, 2010. Patients were stratified into 2 groups based on receipt of VTE prophylaxis; measured outcomes were thromboembolic complications or bleeding within 30 days. There was no significant difference in VTE development between the groups except for those patients with free tissue transfer. Bleeding complications were associated with concomitant use of antiplatelet medications and chemoprophylaxis.
Highlights. JAMA Otolaryngol Head Neck Surg. 2014;140(11):993. doi:10.1001/jamaoto.2013.4320